Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs01491689
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
---|---|---|---|---|---|
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
INP | 4-[[N-[(PHENYLMETHOXY)CARBONYL]- /NL/N-LEUCYL]AMINO]-1[(2S)-2-[[[4- (PYRIDINYLMETHOXY)CARBONYL]AMINO]- 4-METHYLPENT/NYL]-3-PYRROLIDINONE/N | A | 1AU4 | 0.71 | |
DOT | 3'ANTHRANILOYL-2'-DEOXY-ADENOSINE- 5'-TRIPHOSPHATE | A,B,C,D,E,F | 1LVC | 0.72 | |
C24 | 3-({2-[(4-CARBAMIMIDOYL-PHENYLAMINO)- METHYL]-3-METHYL-3H-BENZOIMIDAZOLE- 5-CARBONYL}-PYRIDIN-2-YL-AMINO)- PROPIONIC ACID ETHYL ESTER | B,C | 1KTS | 0.74 | |
AKP | N-(PYRAZIN-2-YLCARBONYL)LEUCYLISOLEUCYL- N~1~-{1-[2-({1-CARBOXY-2-[4-(PHOSPHONOOXY)PHENYL]ETHYL}AMINO)- 1,1-DIHYDROXY-2-OXOETHYL]BUT-3- ENYL}-3-CYCLOHEXYLALANINAMIDE | A,B | 1RGQ | 0.71 | |
ONM | 3'-O-(N-METHYLANTHRANILOYL)-GUANOSINE- 5'-TRIPHOSPHATE | A,C | 1TL7 | 0.74 | |
ONM | 3'-O-(N-METHYLANTHRANILOYL)-GUANOSINE- 5'-TRIPHOSPHATE | A,C | 1U0H | 0.74 | |
PT1 | PTEROIC ACID | A,B | 1TX0 | 0.74 | |
PT1 | PTEROIC ACID | A | 1BR6 | 0.74 | |
PT1 | PTEROIC ACID | A,B | 1HWP | 0.74 | |
AAF | METHYL 4-{[({[(2R,5S)-5-{[(2S)- 2-(AMINOMETHYL)PYRROLIDIN-1-YL]CARBONYL}PYRROLIDIN- 2-YL]METHYL}AMINO)CARBONYL]AMINO}BENZOATE | B | 2G63 | 0.7 | |
4RB | 4-(6-{[(1R)-1-(hydroxymethyl)propyl]amino}imidazo[1,2- b]pyridazin-3-yl)benzoic acid | A | 3BQR | 0.71 | |
608 | N-(4-phenoxyphenyl)-2-[(pyridin- 4-ylmethyl)amino]nicotinamide | A,B | 2P2I | 0.71 | |
627 | N-[(3E)-5-[(2R)-2-METHOXY-2-PHENYLACETYL]PYRROLO[3,4- C]PYRAZOL-3(5H)-YLIDENE]-4-(4-METHYLPIPERAZIN- 1-YL)BENZAMIDE | A,B | 2J50 | 0.74 | |
627 | N-[(3E)-5-[(2R)-2-METHOXY-2-PHENYLACETYL]PYRROLO[3,4- C]PYRAZOL-3(5H)-YLIDENE]-4-(4-METHYLPIPERAZIN- 1-YL)BENZAMIDE | A,B | 2V7A | 0.74 | |
S91 | [4-({5-(AMINOCARBONYL)-4-[(3-METHYLPHENYL)AMINO]PYRIMIDIN- 2-YL}AMINO)PHENYL]ACETIC ACID | A | 2Z8C | 0.72 | |
S91 | [4-({5-(AMINOCARBONYL)-4-[(3-METHYLPHENYL)AMINO]PYRIMIDIN- 2-YL}AMINO)PHENYL]ACETIC ACID | A | 2Z7L | 0.72 | |
CEI | N-[3-BENZYL-5-(4-HYDROXYPHENYL)PYRAZIN- 2-YL]-2-(4-HYDROXYPHENYL)ACETAMIDE | A,B | 2PSJ | 0.7 | |
CEI | N-[3-BENZYL-5-(4-HYDROXYPHENYL)PYRAZIN- 2-YL]-2-(4-HYDROXYPHENYL)ACETAMIDE | A | 2F8P | 0.7 | |
CEI | N-[3-BENZYL-5-(4-HYDROXYPHENYL)PYRAZIN- 2-YL]-2-(4-HYDROXYPHENYL)ACETAMIDE | A | 1S36 | 0.7 | |
BI9 | 2-({5-CHLORO-2-[(2-METHOXY-4-MORPHOLIN- 4-YLPHENYL)AMINO]PYRIMIDIN-4-YL}AMINO)- N-METHYLBENZAMIDE | A | 2JKK | 0.71 | |
4QB | 3-{2-ETHYL-6-[4-(QUINOXALIN-2-YLAMINO)- BENZOYLAMINO]-HEXANOYLAMINO}-4- OXO-BUTYRIC ACID | A | 1RWN | 0.76 | |
PVB | PURVALANOL | A | 1CKP | 0.71 | |
PVB | PURVALANOL | A,B | 1V0P | 0.71 | |
AGN | A | 1GNP | 0.75 | ||
R78 | 4-{[(7R)-8-cyclopentyl-7-ethyl- 5-methyl-6-oxo-5,6,7,8-tetrahydropteridin- 2-yl]amino}-3-methoxy-N-(1-methylpiperidin- 4-yl)benzamide | A | 2RKU | 0.71 | |
MNT | 2'(3')-O-N-METHYLANTHRANILOYL-ADENOSINE- 5'-DIPHOSPHATE | A | 1LVK | 0.72 | |
MT1 | N-(4-{[(2,4-DIAMINOPTERIDIN-1-IUM- 6-YL)METHYL](METHYL)AMINO}BENZOYL)- L-GLUTAMIC ACID | A,B | 2INQ | 0.71 | |
MS3 | N,N-[2,5-O-DIBENZYL-GLUCARYL]-DI- [VALINYL-AMINOMETHANYL-PYRIDINE] | A | 1EC3 | 0.71 | |
APT | 2-AMINO-6-[(4-CARBOXY-PHENYLAMINO)- METHYL]-4-HYDROXY-PTERIDIN-1-IUM | A,B | 1QCJ | 0.72 | |
OQB | 4-OXO-3-[(6-{[4-(QUINOXALIN-2-YLAMINO)- BENZOYLAMINO]-METHYL}-PYRIDINE- 3-CARBONYL)-AMINO]-BUTYRIC ACID | A | 1RWW | 0.75 | |
1IQ | 2-(4-ISOPROPYL-4-METHYL-5-OXO-4,5- DIHYDRO-1H-IMIDAZOL-2-YL)QUINOLINE- 3-CARBOXYLIC ACID | A | 1Z8N | 0.71 | |
NA4 | 4-[5-(2-CARBOXY-1-FORMYL-ETHYLCARBAMOYL)- PYRIDIN-3-YL]-BENZOIC ACID | A,C | 1RHM | 0.7 | |
TIT | N-((3S,4S)-5-[(4-BROMOBENZYL)OXY]- 3-HYDROXY-4-{[N-(PYRIDIN-2-YLCARBONYL)- L-VALYL]AMINO}PENTANOYL)-L-ALANYL- L-LEUCINAMIDE | A,B | 1W6H | 0.73 | |
P10 | [1-(3-HYDROXY-2-OXO-1-PHENETHYL- PROPYLCARBAMOYL)2-PHENYL-ETHYL]- CARBAMIC ACID PYRIDIN-4-YLMETHYL ESTER | A | 1ME3 | 0.72 | |
FE1 | METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN- 6-YL)METHYL](METHYL)AMINO}BENZOYL)PIPERIDINE- 4-CARBOXYLATE | A,B,C,D | 2QHX | 0.71 | |
OAI | 6-(OXALYL-AMINO)-1H-INDOLE-5-CARBOXYLIC ACID | A | 1C83 | 0.71 | |
2SM | methyl 2-{[(4-methylpyrimidin-2- yl)carbamoyl]sulfamoyl}benzoate | A | 3EA4 | 0.7 | |
FOL | FOLIC ACID | A | 1PJ6 | 0.78 | |
FOL | FOLIC ACID | A,B | 1RD7 | 0.78 | |
FOL | FOLIC ACID | A,B | 1DHF | 0.78 | |
FOL | FOLIC ACID | A,B,C,D,E | 1QZF | 0.78 | |
FOL | FOLIC ACID | A | 4CD2 | 0.78 | |
FOL | FOLIC ACID | A | 1RX7 | 0.78 | |
FOL | FOLIC ACID | A | 1RX2 | 0.78 | |
FOL | FOLIC ACID | A | 1RX8 | 0.78 | |
FOL | FOLIC ACID | A | 1RA2 | 0.78 | |
FOL | FOLIC ACID | A,B | 1RE7 | 0.78 | |
FOL | FOLIC ACID | A | 7DFR | 0.78 | |
FOL | FOLIC ACID | A | 1VIF | 0.78 | |
FOL | FOLIC ACID | A,B | 1RB2 | 0.78 | |
FOL | FOLIC ACID | A | 1CD2 | 0.78 | |
FOL | FOLIC ACID | A | 2CD2 | 0.78 | |
FOL | FOLIC ACID | A,B | 1DYI | 0.78 | |
FOL | FOLIC ACID | A | 1DRF | 0.78 | |
FOL | FOLIC ACID | A,B,C,D | 3BMC | 0.78 | |
FOL | FOLIC ACID | A,B | 2D0K | 0.78 | |
FOL | FOLIC ACID | A | 1RA8 | 0.78 | |
ONO | 2-[2-({[4-(DIAMINOMETHYL)PHENYL]AMINO}CARBONYL)- 6-METHOXYPYRIDIN-3-YL]-5-{[(1-FORMYL- 2,2-DIMETHYLPROPYL)AMINO]CARBONYL}BENZOIC ACID | A | 2AYW | 0.71 | |
NFL | 2-{[3-(TRIFLUOROMETHYL)PHENYL]AMINO}NICOTINIC ACID | A | 1TD7 | 0.74 | |
35A | N-[(5R,14R)-5-AMINO-5,14-DIMETHYL- 4-OXO-3-OXA-18-AZATRICYCLO[15.3.1.1~7,11~]DOCOSA- 1(21),7(22),8,10,17,19-HEXAEN-19- YL]-N-METHYLMETHANESULFONAMIDE | A | 2PH8 | 0.71 | |
RUN | 2-[(1R,3S,4S)-1-BENZYL-4-[N-(BENZYLOXYCARBONYL)- L-VALYL]AMINO-3-PHENYLPENTYL]-4(5)- (2-METHYLPROPIONYL)IMIDAZOLE | B | 1HPS | 0.7 | |
GK6 | N-{4'-[(cyclopropylmethyl)carbamoyl]- 6-methylbiphenyl-3-yl}-2-morpholin- 4-ylpyridine-4-carboxamide | A | 3D83 | 0.7 | |
24X | H,L | 2EC9 | 0.72 | ||
368 | (1R)-2-{[AMINO(IMINO)METHYL]AMINO}- 1-{4-[(4R)-4-(HYDROXYMETHYL)-1,3,2- DIOXABOROLAN-2-YL]PHENYL}ETHYL NICOTINATE | A | 1ZLR | 0.76 | |
MTX | METHOTREXATE | A,B | 1DRB | 0.72 | |
MTX | METHOTREXATE | A,B,C,D | 2C7V | 0.72 | |
MTX | METHOTREXATE | A | 1U70 | 0.72 | |
MTX | METHOTREXATE | A,B,C,D | 1MXF | 0.72 | |
MTX | METHOTREXATE | A | 2QK8 | 0.72 | |
MTX | METHOTREXATE | A,B | 1RB3 | 0.72 | |
MTX | METHOTREXATE | A,B | 1DHJ | 0.72 | |
MTX | METHOTREXATE | A | 3DAU | 0.72 | |
MTX | METHOTREXATE | A | 1U72 | 0.72 | |
MTX | METHOTREXATE | A,B | 2DRC | 0.72 | |
MTX | METHOTREXATE | A,B | 1D1G | 0.72 | |
MTX | METHOTREXATE | A,B | 1DDR | 0.72 | |
MTX | METHOTREXATE | A,B | 1E7W | 0.72 | |
MTX | METHOTREXATE | A | 1RX3 | 0.72 | |
MTX | METHOTREXATE | A | 3DFR | 0.72 | |
MTX | METHOTREXATE | A,B,C,D | 1P33 | 0.72 | |
MTX | METHOTREXATE | A | 3DAT | 0.72 | |
MTX | METHOTREXATE | A,B | 1DHI | 0.72 | |
MTX | METHOTREXATE | A,B | 1TDR | 0.72 | |
MTX | METHOTREXATE | A,B | 1DRA | 0.72 | |
MTX | METHOTREXATE | A | 3EIG | 0.72 | |
MTX | METHOTREXATE | A | 3CD2 | 0.72 | |
MTX | METHOTREXATE | A | 1AO8 | 0.72 | |
MTX | METHOTREXATE | A | 1DF7 | 0.72 | |
MTX | METHOTREXATE | A | 1DLS | 0.72 | |
MTX | METHOTREXATE | A | 1RG7 | 0.72 | |
MTX | METHOTREXATE | A | 1RH3 | 0.72 | |
MTX | METHOTREXATE | A,B | 4DFR | 0.72 | |
MTX | METHOTREXATE | A | 1RA3 | 0.72 | |
MTX | METHOTREXATE | A,B | 1DDS | 0.72 | |
MTX | METHOTREXATE | A | 1DRE | 0.72 | |
MTX | METHOTREXATE | A,B | 1AXW | 0.72 | |
MTX | METHOTREXATE | A | 3CL9 | 0.72 | |
MTX | METHOTREXATE | A,B | 3DRC | 0.72 | |
MTX | METHOTREXATE | A,B,C,D,E | 2OIP | 0.72 | |
C92 | N'-(6-aminopyridin-3-yl)-N-(2-cyclopentylethyl)- 4-methyl-benzene-1,3-dicarboxamide | A,B | 3CPB | 0.71 | |
BO2 | N-[(1R)-1-(DIHYDROXYBORYL)-3-METHYLBUTYL]- N-(PYRAZIN-2-YLCARBONYL)-L-PHENYLALANINAMIDE | 2,H,K,N,V,Y | 2F16 | 0.7 | |
DZF | 5-DEAZAFOLIC ACID | A,B | 2DHF | 0.73 | |
DZF | 5-DEAZAFOLIC ACID | A,B | 1DYH | 0.73 | |
DZF | 5-DEAZAFOLIC ACID | A,B,C,D | 1CDE | 0.73 | |
COP | N-(4-CARBOXY-4-{4-[(2,4-DIAMINO- PTERIDIN-6-YLMETHYL)-AMINO]-BENZOYLAMINO}- BUTYL)-PHTHALAMIC ACID | A | 1OHJ | 0.75 | |
COP | N-(4-CARBOXY-4-{4-[(2,4-DIAMINO- PTERIDIN-6-YLMETHYL)-AMINO]-BENZOYLAMINO}- BUTYL)-PHTHALAMIC ACID | A | 1OHK | 0.75 | |
MR9 | 4-METHYL-3-({3-[2-(METHYLAMINO)PYRIMIDIN- 4-YL]PYRIDIN-2-YL}OXY)-N-[2-MORPHOLIN- 4-YL-5-(TRIFLUOROMETHYL)PHENYL]BENZAMIDE | A,B | 2P4I | 0.71 | |
T19 | PHENYLMETHYLENECARBOXY-(METHYLENEAMINO- FORMYL-DIPHENYLMETHYL)METHY-PRO- BOROVAL | H,I | 1AIX | 0.72 | |
NTM | QUINOLINIC ACID | A | 3C2O | 0.7 | |
NTM | QUINOLINIC ACID | A,B | 1QAP | 0.7 | |
NTM | QUINOLINIC ACID | A,B,C,D,E,F | 1QPQ | 0.7 | |
NTM | QUINOLINIC ACID | A,B,C | 2B7N | 0.7 | |
PD8 | PHOSPHORYLATED DIHYDROPTEROATE | A | 1W78 | 0.82 | |
CBB | 1-(3-CARBAMIMIDOYL-BENZYL)-1H-INDOLE- 2-CARBOXYLIC ACID 3-CARBAMIMIDOYL- BENZYLESTER | B | 1LPK | 0.73 | |
DVP | METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN- 6-YL)METHYL]AMINO}BENZOYL)PIPERIDINE- 4-CARBOXYLATE | A,B,C,D,E,F, G,H | 3H4V | 0.71 | |
859 | 2-({2-[(3-HYDROXYPHENYL)AMINO]PYRIMIDIN- 4-YL}AMINO)BENZAMIDE | A,B | 2NO3 | 0.7 | |
ONA | A,C | 2GVZ | 0.72 | ||
3IN | N-[2(S)-CYCLOPENTYL-1(R)-HYDROXY- 3(R)METHYL]-5-[(2(S)-TERTIARY-BUTYLAMINO- CARBONYL)-4-(N1-(2)-(N-METHYLPIPERAZINYL)- 3-CHLORO-PYRAZINYL-5-CARBONYL)- PIPERAZINO]-4(S)-HYDROXY-2(R)-PHENYLMETHYL- PENTANAMIDE | B | 2BPZ | 0.7 | |
3IN | N-[2(S)-CYCLOPENTYL-1(R)-HYDROXY- 3(R)METHYL]-5-[(2(S)-TERTIARY-BUTYLAMINO- CARBONYL)-4-(N1-(2)-(N-METHYLPIPERAZINYL)- 3-CHLORO-PYRAZINYL-5-CARBONYL)- PIPERAZINO]-4(S)-HYDROXY-2(R)-PHENYLMETHYL- PENTANAMIDE | B | 2BPY | 0.7 | |
3IN | N-[2(S)-CYCLOPENTYL-1(R)-HYDROXY- 3(R)METHYL]-5-[(2(S)-TERTIARY-BUTYLAMINO- CARBONYL)-4-(N1-(2)-(N-METHYLPIPERAZINYL)- 3-CHLORO-PYRAZINYL-5-CARBONYL)- PIPERAZINO]-4(S)-HYDROXY-2(R)-PHENYLMETHYL- PENTANAMIDE | B | 1C6X | 0.7 |